Jung Ha Kim Selected Research

Jung Ha Kim Research Topics

Disease

12	Coronary Restenosis 01/2021 - 05/2010
10	Inflammation (Inflammations) 08/2017 - 09/2011
8	Hyperplasia 08/2017 - 05/2010
8	Neointima 01/2017 - 05/2011
7	Pathologic Constriction (Stenosis) 01/2021 - 09/2011
4	Neoplasms (Cancer) 10/2023 - 05/2016
3	Bone Resorption 01/2015 - 05/2004
2	Osteoporosis 10/2023 - 05/2020
2	Thrombosis (Thrombus) 07/2022 - 04/2015
2	MASS syndrome 01/2019 - 02/2016
2	Infarction (Infarctions) 01/2015 - 02/2011
2	Myocardial Infarction 01/2015 - 02/2011
1	Metabolic Diseases (Metabolic Disease) 10/2023
1	Bone Diseases (Bone Disease) 03/2023
1	Arteritis 07/2022
1	Levin type Osteogenesis imperfecta 01/2019
1	Osteoarthritis 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Syncope (Fainting) 03/2017
1	Burns 03/2017
1	Cerebellar Ataxia (Dysmetria) 01/2017
1	Malaria 01/2017
1	Meckel syndrome type 3 01/2017
1	COACH syndrome 01/2017
1	Congenital Hepatic Fibrosis 01/2017
1	Carcinoma (Carcinomatosis) 05/2016
1	Stomach Neoplasms (Stomach Cancer) 05/2016
1	Adenocarcinoma 05/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Ureteral Obstruction 01/2016
1	Necrosis 04/2015
1	Cardiomegaly (Heart Hypertrophy) 05/2014
1	Hypertrophy 05/2014
1	Body Weight (Weight, Body) 05/2014
1	Spasm (Spasms) 06/2012
1	Multiple Myeloma 05/2012
1	Chronic Hepatitis C 02/2007

Drug/Important Bio-Agent (IBA)

7	FibrinIBA 01/2021 - 04/2013
5	PolymersIBA 07/2022 - 11/2014
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2015
3	Thioctic Acid (Lipoic Acid)IBA 04/2016 - 05/2011
2	Everolimus FDA Link 11/2016 - 11/2013
2	3,3',4,5'-tetrahydroxystilbeneIBA 01/2016 - 05/2014
2	Ezetimibe (Zetia)FDA Link 03/2015 - 05/2010
2	Simvastatin (Zocor)FDA LinkGeneric 03/2015 - 05/2010
2	Abciximab (ReoPro)FDA Link 11/2014 - 05/2011
2	BESIBA 11/2014 - 11/2013
2	MetalsIBA 04/2013 - 05/2011
1	ginsenoside Rg2IBA 10/2023
1	GinsenosidesIBA 10/2023
1	Therapeutic UsesIBA 10/2023
1	Small Interfering RNA (siRNA)IBA 03/2023
1	Anabolic AgentsIBA 05/2020
1	Bone Density Conservation AgentsIBA 05/2020
1	AnoctaminsIBA 01/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	methylmethacrylate-methacrylic acid copolymerIBA 07/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	PalmitatesIBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Oleic Acid (Oleate)IBA 01/2018
1	Casein Kinase II (Casein Kinase 2)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 09/2017
1	Prasugrel Hydrochloride FDA Link 08/2017
1	Clopidogrel (Plavix)FDA Link 08/2017
1	TicagrelorIBA 08/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Guanosine Triphosphate (GTP)IBA 01/2017
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017
1	artemisinin (artemisinine)IBA 01/2017
1	artenimol (dihydroartemisinin)IBA 01/2017
1	titanium dioxide (Titania)FDA Link 11/2016
1	NitrogenIBA 11/2016
1	astaxanthine (astaxanthin)IBA 05/2016
1	Sirolimus (Rapamycin)FDA Link 04/2016
1	Drug CombinationsIBA 04/2016
1	Tartrate-Resistant Acid PhosphataseIBA 02/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	p38 Mitogen-Activated Protein KinasesIBA 01/2016
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2016
1	Connective Tissue Growth FactorIBA 01/2015
1	Angiotensin Receptor AntagonistsIBA 01/2015
1	fimasartanIBA 01/2015
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2014
1	GATA Transcription FactorsIBA 05/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2013
1	zotarolimusIBA 11/2013
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2012
1	Interleukin-3 (Interleukin 3)IBA 05/2012
1	ramiprilatIBA 09/2011
1	Angiotensin IIIBA 09/2011
1	Sildenafil Citrate (Viagra)FDA Link 02/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2011
1	Cathepsin KIBA 07/2009
1	Interferon-alpha (Interferon Alfa)IBA 02/2007

Therapy/Procedure

12	Stents 07/2022 - 05/2011
6	Drug-Eluting Stents 01/2017 - 05/2010
3	Therapeutics 07/2018 - 02/2007
1	First Aid (Aids, First) 03/2017